Compare BridgeBio Pharma Inc (BBIO) vs Bilibili Inc (BILI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Bilibili Inc — how do they compare? BridgeBio Pharma Inc trades at $82.63 (market cap $16.46B), while Bilibili Inc trades at $18.39 (market cap $7.35B). The key difference: BridgeBio Pharma Inc is far larger — about 2.2× Bilibili Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Bilibili Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | BILI | |
|---|---|---|
Market Cap | $16.46B | $7.35B |
Sector | Health | Media |
52-Week High | $90.17 | $35.92 |
52-Week Low | $44.81 | $15.96 |
Enterprise Value | $18.02B | $5.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Bilibili (BILI) trades at $17.59, down 0.62% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.19, beating expectations, and maintains strong analyst support with 83.3% buy ratings. Revenue growth is steady, projected at $30.8B for 2026, with improving net income margins. Recent news highlights a new $300 million share repurchase program, signaling confidence in long-term value.
The outlook for BILI is cautiously optimistic, driven by earnings beats and shareholder-friendly actions, but risks include competitive pressures in the Chinese digital media space and technical bearishness. Upside potential hinges on sustained user growth and margin expansion, while volatility from market sentiment poses a near-term challenge.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Bilibili Inc
Bilibili is a leading video sharing and online entertainment platform for Gen Z in China. It offers a diverse range of content, including anime, games, and live broadcasting, fueled by a highly engaged community.
Read more on BILI →
